Skip to content

Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids

Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05894109
Enrollment
0
Registered
2023-06-08
Start date
2024-08-31
Completion date
2024-10-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjuvant Oral Zinc and Botulinum Toxin, Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin, Botulinum Toxin, Cosmetic, Glabellar Frown Lines, Zinc Supplementation for Botulinum Toxin Treatment of the Forehead

Brief summary

The current literature suggests that zinc supplementation may increase the duration of botulinum toxin; however, each study had their limitations. Further, no one has studied the effect of zinc supplementation for botulinum toxin treatment of the forehead. The purpose of this study is to evaluate the effect of zinc supplementation on frontalis muscle denervation by objectively assessing the degree of forehead rhytids and movement of the eyebrows.

Interventions

DIETARY_SUPPLEMENTzinc citrate 50 mg

will take zinc citrate 4 days before and 1 week after botulinum toxin injection

will take placebo 4 days before and 1 week after botulinum toxin injection

Sponsors

AbbVie
CollaboratorINDUSTRY
University of New Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Repeated Measures ANOVA (Continuous Data) McNemar Test (Categorical Data)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Any patient older than 18 years old who desires botulinum toxin injection to decrease forehead rhytids

Exclusion criteria

* Allergy to any components of zinc citrate or botulinum toxin * inflammation or infection at site of injection * patients using anticholineresterase or other agents interfering with neuromuscular transmission * patients with any medical condition that can affect frontalis function (Bell's palsy, Möbius syndrome, Hemifacial microsomia, CHARGE syndrome, stroke, etc) * patients with any prior trauma that could have potentially injured the frontalis muscle * patients dependent on intact facial movements and expressions for their livelihood (actors, singers, musicians, etc)

Design outcomes

Primary

MeasureTime frameDescription
Duration of botulinum toxin on eyebrow excursion1 yearMeasurement of eyebrow excursion
Duration of botulinum toxin effect on forehead rhytids1 yearVisual assessment of return of forehead rhytids

Secondary

MeasureTime frameDescription
Side effects of zinc administration1 yearMonitor for adverse side effects of adjunct oral zinc therapy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026